REGN5459
Regeneron
['regn5459']
happening now at #aacr23: of / is discussing a phase i study of regn5459, a bispecific antibody targeting bcma and cd3, in pts with relapsed or refractory mm.
Translating Hematologic Oncology Discoveries into Practice.